Vertex Pharmaceuticals, Inc. (VRTX)
435.50
-1.51
(-0.35%)
USD |
NASDAQ |
Dec 10, 12:53
Vertex Pharmaceuticals EPS Diluted (Quarterly): 4.204 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Amgen, Inc. | 5.934 |
| Eli Lilly & Co. | 6.211 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.083B |
| Revenue (Quarterly) | 3.115B |
| Total Expenses (Quarterly) | 2.032B |
| Enterprise Value | 106.42B |
| Gross Profit Margin (Quarterly) | 86.69% |
| Profit Margin (Quarterly) | 34.76% |
| Earnings Yield | 3.26% |
| Operating Earnings Yield | 4.01% |
| Normalized Earnings Yield | 3.593 |